Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Boulmé

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
FEBS Letters|August 4, 1998
Initiation of in vitro reverse transcription from tRNA(Lys3) on HIV-1 or HIV-2 RNAs by both type 1 and 2 reverse transcriptasesF Boulmé, F Freund, S Litvak
Nucleic Acids Research|July 4, 2001
Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplexF Freund, F Boulmé, S Litvak, et al.
Biotechniques|June 21, 2001
Reliability of mRNA profiling: verification for samples with different complexitiesB Pradet-Balade, F Boulmé, E W Müllner, et al.
Antisense & Nucleic Acid Drug Development|January 5, 2002
Inhibition of HIV-1 replication in vitro and in human infected cells by modified antisense oligonucleotides targeting the tRNALys3/RNA initiation complexF Freund, F Boulmé, J Michel, et al.
European Journal of Biochemistry|April 28, 2000
Study of HIV-2 primer-template initiation complex using antisense oligonucleotidesF Boulmé, F Freund, S Gryaznov, et al.
Biochimica Et Biophysica Acta|April 21, 1999
Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNAB Mestre, A Arzumanov, M Singh, et al.
Trends in Biochemical Sciences|April 11, 2001
Translation control: bridging the gap between genomics and proteomics?B Pradet-Balade, F Boulmé, H Beug, et al.
Nucleic Acids Research|November 25, 1998
Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcriptionF Boulmé, F Freund, S Moreau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 2, 2001
Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arraysH Dolznig, F Boulmé, K Stangl, et al.
European Journal of Biochemistry|March 10, 1998
p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitorsE Dufour, R El Dirani-Diab, F Boulmé, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
FEBS Letters|August 4, 1998
Initiation of in vitro reverse transcription from tRNA(Lys3) on HIV-1 or HIV-2 RNAs by both type 1 and 2 reverse transcriptasesF Boulmé, F Freund, S Litvak
Nucleic Acids Research|July 4, 2001
Initiation of HIV-2 reverse transcription: a secondary structure model of the RNA-tRNA(Lys3) duplexF Freund, F Boulmé, S Litvak, et al.
Biotechniques|June 21, 2001
Reliability of mRNA profiling: verification for samples with different complexitiesB Pradet-Balade, F Boulmé, E W Müllner, et al.
Antisense & Nucleic Acid Drug Development|January 5, 2002
Inhibition of HIV-1 replication in vitro and in human infected cells by modified antisense oligonucleotides targeting the tRNALys3/RNA initiation complexF Freund, F Boulmé, J Michel, et al.
European Journal of Biochemistry|April 28, 2000
Study of HIV-2 primer-template initiation complex using antisense oligonucleotidesF Boulmé, F Freund, S Gryaznov, et al.
Biochimica Et Biophysica Acta|April 21, 1999
Oligonucleotide inhibition of the interaction of HIV-1 Tat protein with the trans-activation responsive region (TAR) of HIV RNAB Mestre, A Arzumanov, M Singh, et al.
Trends in Biochemical Sciences|April 11, 2001
Translation control: bridging the gap between genomics and proteomics?B Pradet-Balade, F Boulmé, H Beug, et al.
Nucleic Acids Research|November 25, 1998
Modified (PNA, 2'-O-methyl and phosphoramidate) anti-TAR antisense oligonucleotides as strong and specific inhibitors of in vitro HIV-1 reverse transcriptionF Boulmé, F Freund, S Moreau, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 2, 2001
Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arraysH Dolznig, F Boulmé, K Stangl, et al.
European Journal of Biochemistry|March 10, 1998
p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitorsE Dufour, R El Dirani-Diab, F Boulmé, et al.
Pageof 1